SO
MBX

STRS Ohio’s MBX Biosciences MBX Stock Holding History

STRS Ohio’s Portfolio MBX Stock Details MBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$110K Buy
2,000
+400
+25% +$14K ﹤0.01% 1842
2026
Q1 		$47.8K Buy
1,600
+900
+129% +$30.6K ﹤0.01% 1942
2025
Q4 		$22.1K Hold
700
– – ﹤0.01% 2100
2025
Q3 		$12.3K Hold
700
– – ﹤0.01% 2144
2025
Q2 		$7.99K Hold
700
– – ﹤0.01% 2171
2025
Q1 		$5.17K Sell
700
-1,400
-67% -$14.8K ﹤0.01% 1895
2024
Q4 		$38.7K Buy
+2,100
New +$44.8K ﹤0.01% 1756

Other funds holding MBX

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $328M AUM 166.51% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

STRS Ohio's MBX Position: Q2 2026 in Review

STRS Ohio increased its MBX Biosciences (MBX) stake by 25% in Q2 2026, buying an estimated $14K and bringing the position to 2,000 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #1842.

STRS Ohio first reported a position in MBX in Q4 2024 and has held it in 7 quarters since. 172 funds tracked by Wall St. Rank hold MBX as of Q2 2026.

  • STRS Ohio held 2,000 shares of MBX Biosciences worth $110K as of Q2 2026.
  • STRS Ohio bought 400 MBX Biosciences shares in Q2 2026, an estimated $14K.
  • MBX Biosciences made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #1842 holding.
  • STRS Ohio first reported a position in MBX Biosciences in Q4 2024 and has held it in 7 quarters since.
  • 172 funds tracked by Wall St. Rank held MBX Biosciences as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.